Cardiology

Iliac vein stenting appears safe in office-based lab setting

(HealthDay)—Iliac vein stenting seems safe in an office-based laboratory (OBL) setting, with few major complications and minor complications primarily including insertion site hematomas, according to a study published in ...

Medications

FDA approves IV artesunate for severe malaria

Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat adults and children with severe malaria, the agency announced Tuesday.

Medications

Serelaxin does not lower CV death in acute heart failure

(HealthDay)—An infusion of serelaxin does not result in a lower incidence of death from cardiovascular causes or worsening of heart failure among patients hospitalized for acute heart failure, according to a study published ...

Diseases, Conditions, Syndromes

Renal-replacement timing has no effect in kidney injury, sepsis

(HealthDay)—For patients with early-stage septic shock and severe acute kidney injury, 90-day mortality does not differ for patients randomly assigned to an early strategy for initiation of renal-replacement therapy versus ...

Cardiology

PCI, CABG both acceptable for CKD patients with LMCAD

(HealthDay)—For patients with left main coronary artery disease (LMCAD), those with and without chronic kidney disease (CKD) undergoing revascularization have similar long-term outcomes with percutaneous coronary intervention ...

page 2 from 7